| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/23/2003 | US20030018002 Gene therapy |
| 01/23/2003 | US20030017991 Substrates and assays for beta-secretase activity |
| 01/23/2003 | US20030017984 Binding to ligand; crystallization; cardiovascular disorders; Alzheimer's disease |
| 01/23/2003 | US20030017982 Genetic engineering; hybrid nucleic acids |
| 01/23/2003 | US20030017981 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017980 Detecting breast cancer |
| 01/23/2003 | US20030017971 Method for increasing levels of export of mRNA from the nucleus to the cytoplasm by providing in the nucleus recombinant mammalian export protein ALY |
| 01/23/2003 | US20030017969 Methods and pharmaceutical compositions for healing wounds |
| 01/23/2003 | US20030017967 Insecticides; microbiocides; for plants, seeds |
| 01/23/2003 | US20030017966 MC4-R as target for the identification of compounds used to treat drug addiction |
| 01/23/2003 | US20030017964 Administration of agents via the PEPT-2 transporter |
| 01/23/2003 | US20030017618 Apparatus for use in the detection of preferential particles in sample |
| 01/23/2003 | US20030017617 Mammalian receptor proteins; related reagents and methods |
| 01/23/2003 | US20030017601 Expression vector for transferring preferential nucleotide sequences into mammalian cells |
| 01/23/2003 | US20030017600 Double selection vector |
| 01/23/2003 | US20030017599 Applying nonionic organosilicone surfactant with kanamycin and/or paromomycin facilitates detection of neomycin phosphotransferase II protein in transgenic plants (corn) |
| 01/23/2003 | US20030017598 Method and apparatus for targeting localised electroporation |
| 01/23/2003 | US20030017597 Expression vector for use in human diagnositics and therapeutics |
| 01/23/2003 | US20030017594 Propagation of preferential nucleotide sequences; obtain cell, transform with preferential vector, propagate cell, extract amplified vector nucleotide sequences |
| 01/23/2003 | US20030017593 Vector for use as tool in gene therapy |
| 01/23/2003 | US20030017592 Amplification of translational product; obtain cell, transform with vector containing polypeptide of interest, express vector, recover polypeptide, compare expression to wild type |
| 01/23/2003 | US20030017589 Culturing preferential cells; generate nutrient broth, inoculate with cells, propagate cells, recover cells |
| 01/23/2003 | US20030017586 Nucleotide sequences coding polypeptide for use in the treatment of viral diseases |
| 01/23/2003 | US20030017585 Polypeptide for use in the treatment of cancer, nervous system and autoimmune disorders |
| 01/23/2003 | US20030017576 Production of medium chain length polyhydroxyalkanoates from fatty acid biosynthetic pathways |
| 01/23/2003 | US20030017575 Cell-wall degrading enzyme variants |
| 01/23/2003 | US20030017572 Nucleotide sequences coding polypeptides for use in the treatment of cancer, arthritis alzheimer's and inflammatory diseases |
| 01/23/2003 | US20030017571 Polynucleotide compositions encoding broad spectrum delta-endotoxins |
| 01/23/2003 | US20030017570 Chitinase materials and methods |
| 01/23/2003 | US20030017567 Composition for use as analytical tool in polymerase chain reaction |
| 01/23/2003 | US20030017566 Polypeptide for use in prevention of parasitic infection in plants |
| 01/23/2003 | US20030017564 Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiogenesis |
| 01/23/2003 | US20030017563 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017562 Nucleotide sequences coding polypetide for use in the treatment, prevention and diagnosis of gastrointestinal and apoptosis disorders |
| 01/23/2003 | US20030017557 Nucleotide sequences coding amino acid for use in human medicines and nutrient broths |
| 01/23/2003 | US20030017556 Generation of preferential amino acid; obtain microorganism, transform with vector, propagate microorganism, express vector, ferment and recover amino acid |
| 01/23/2003 | US20030017553 Nucleotide sequences for transcriptional regulation in corynebacterium glutamicum |
| 01/23/2003 | US20030017552 Modular vector systems |
| 01/23/2003 | US20030017551 Biological sample processing methods and compositions that include surfactants |
| 01/23/2003 | US20030017549 Nucleotide sequences coding polypeptide for use in the treatment of atherosclerosis, hypertension, stroke, asthma, gastrointestinal, urogenital and sexual disorders |
| 01/23/2003 | US20030017548 Proteins for use in treatment of gastrointestinal disorders |
| 01/23/2003 | US20030017547 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 01/23/2003 | US20030017538 Genetically engineered protein for use as diagnostic tool in gentic analysis |
| 01/23/2003 | US20030017537 Amplified genetic expression of genetically engineered hemoglobin; obtain cell, transform with vector coding genetically engineered hemoglobin, express vector, recover hemoglobin |
| 01/23/2003 | US20030017535 Nucleotide sequences coding polypeptide for use in the prevention and treatment of atherosclerosis, cardiovascular and cancerous disorders |
| 01/23/2003 | US20030017534 Production of humanized antibodies in transgenic animals |
| 01/23/2003 | US20030017533 Slo2 and Slo4, novel potassium channel proteins from human brain |
| 01/23/2003 | US20030017532 ndp |
| 01/23/2003 | US20030017527 Human vanilloid receptor-like proteins |
| 01/23/2003 | US20030017512 Angiostatin receptor |
| 01/23/2003 | US20030017510 Apparatus for use in cell transplantation |
| 01/23/2003 | US20030017504 Antibodies specific for poly(ethylene glycol) |
| 01/23/2003 | US20030017502 Methods involving the use of capG as a diagnostic marker and methods for the identification of capG modulators for the treatment and prevention of osteoporosis and related disease states |
| 01/23/2003 | US20030017495 Enterococcus faecalis polynucleotides and polypeptides |
| 01/23/2003 | US20030017494 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 01/23/2003 | US20030017491 Chromogenic in situ hybridization methods, kits, and compositions |
| 01/23/2003 | US20030017490 Detection preferentially expressed messenger nucleotide sequence; obtain nucleotide sequences, incubate with restricition enzymes, expose to electrophoresis, incubate with probe, detect signal from probe, monitor migration pattern |
| 01/23/2003 | US20030017488 Method for testing a therapeutic or preventive agent for hyperlipidemia |
| 01/23/2003 | US20030017486 Method for preparation of RNA probe, method for detecting targeted nucleic acid, and kit for preparation of RNA probe |
| 01/23/2003 | US20030017483 Modulation of molecular interaction sites on RNA and other biomolecules |
| 01/23/2003 | US20030017482 PCR method |
| 01/23/2003 | US20030017481 Methods for classifying samples and ascertaining previously unknown classes |
| 01/23/2003 | US20030017480 Novel genes encoding protein kinase/protein phosphatase |
| 01/23/2003 | US20030017479 Methods for the detection, treatment, and prevention of neurodegeneration |
| 01/23/2003 | US20030017478 Collection of prokaryotic DNA for two hybrid systems Helicobacter pylori protein-protein interactions and application thereof |
| 01/23/2003 | US20030017477 Generation of homologously recombined nucleotide sequences; obtain nucleotide sequences, denature, incubate with single stranded nucleotide sequences, hybridize and amplify sequences, recover libbrary of sequences |
| 01/23/2003 | US20030017476 Nucleotide sequence coding polypeptide for use in the treatment and diagnosis of nervous system disorders |
| 01/23/2003 | US20030017475 Method for detecting DNA polymorphism applying triple strand DNA formation technique |
| 01/23/2003 | US20030017471 Universal variable fragments |
| 01/23/2003 | US20030017470 Novel PRKAG3 alleles and use of the same as genetic markers for reproductive and meat quality traits |
| 01/23/2003 | US20030017468 Nucleotide sequences which code lung preferential gene for use in the treatment and diagnosis of lung cancer |
| 01/23/2003 | US20030017466 Diagnosi and treatment of cancer; obtain tissue sample, monitor gene expression in sample, monitor methylation in sample, compare to control, evaluate for cancer |
| 01/23/2003 | US20030017465 Use of fluorescent molecular beacons in the detection of methylated nucleic acids |
| 01/23/2003 | US20030017458 Classification of human leukocyte antigen alleles; obtain nucleotide sequences, incubate with primers, amplify, sequence, classify alleles |
| 01/23/2003 | US20030017457 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
| 01/23/2003 | US20030017452 Nucleotide sequences coding polypeptide for use in the prevention and treatment of infections and cancer |
| 01/23/2003 | US20030017450 Detection of viral nucleotide sequences in sample; obtain sample, denature, incubate with pimers, hybridize, amplify, expose to probe, detect signal presence indicates viral nucleotide sequences |
| 01/23/2003 | US20030017196 Oligonucleotide inhibitors of bcl-xL |
| 01/23/2003 | US20030017174 Containing herpes simplex virus VP22 polypeptides capable of eliciting a cellular immune response |
| 01/23/2003 | US20030017172 Feline polynucleotide vaccine formula |
| 01/23/2003 | US20030017161 Polypeptides that are capable of modulating apoptosis; also Apo-2 chimeras, nucleic acid encoding Apo-2, and antibodies to Apo-2 |
| 01/23/2003 | US20030017160 Human checkpoint kinase, hCDS1, compositions and methods |
| 01/23/2003 | US20030017157 Endothelial cell expression patterns |
| 01/23/2003 | US20030017156 Immunogenic polypeptide |
| 01/23/2003 | US20030017153 Determining whether a patient's immune system can be modified through stimulation of thymus function; sex steroids are ablated in the patient, and the resulting production of thymic factors is monitored. |
| 01/23/2003 | US20030017150 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses |
| 01/23/2003 | US20030017147 Novel alpha-2-antiplasmin- binding molecules and treatment for pulmonary embolism, myocardial infarction, thrombosis or stroke in a patient |
| 01/23/2003 | US20030017140 Retroviral vector particles have a chimeric envelope protein consisting of an antigen binding site of an antibody or another peptide, fused to the envelope protein the retroviral vector. |
| 01/23/2003 | US20030017139 Regulatory elements for delivery to the liver |
| 01/23/2003 | US20030017138 Chimeric adenoviruses |
| 01/23/2003 | US20030017134 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 01/23/2003 | US20030015428 Dielectrically-engineered microparticles |
| 01/23/2003 | CA2707767A1 Biologically active peptides |
| 01/23/2003 | CA2485735A1 Plant transcriptional repressor, proteic nuclear factors binding thereto, and uses thereof |
| 01/23/2003 | CA2455615A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/23/2003 | CA2455542A1 Mutated photoproteins and their uses |
| 01/23/2003 | CA2454181A1 Use of corticotroph-derived glycoprotein hormone to induce lipolysis |
| 01/23/2003 | CA2454135A1 Gpcs as modifiers of the irrtk and p21 pathways and methods of use |
| 01/23/2003 | CA2454127A1 Expression cassette comprising an arabidopsis thaliana triose phosphate translocator promoter______________ |
| 01/23/2003 | CA2453928A1 Cell and transgenic animal modelling human antigenic presentation and their uses |